Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation-based veterinary enterprise. Veyong has two production bases: Shijiazhuang and Ordos, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own-label preparations, and OEM & ODM service.
Handan Jiaxin Liupin Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research and development, production and sales of veterinary drugs. Founded in 2014 and located in Handan, Hebei Province, the company has high-standard production workshops, advanced production equipment and advanced research laboratories, and is committed to providing safe, effective and high-quality veterinary products. The company's product range includes veterinary antibiotics, vaccines, antiparasitic drugs and nutritional supplements, with large-volume non-intravenous injections (including Chinese medicine extracts)/oral solutions (including Chinese medicine extracts), tablets/pills/injections/suspensions and other veterinary drugs to meet the health needs of livestock, poultry and pets.
Founded in 2019, our journey has been one of strategic evolution: From a regional pharmaceutical intermediate trader to a globally recognized partner for integrated cross-border supply and technical solutions. With over six years of concentrated expertise in the pharmaceutical and fine chemical sectors, we are dedicated to the mission of "Empowering Pharmaceutical Innovation. " By proactively navigating industry shifts and capitalizing on emerging opportunities, we have established a reputation for reliability and built solid, enduring partnerships across the globe.